TobaccoReporter logo

Category: Around the Industry

  • FDA Authorizes Six on! PLUS Nicotine Pouch Products

    FDA Authorizes Six on! PLUS Nicotine Pouch Products

    The U.S. FDA authorized the marketing of six nicotine pouch products from Helix Innovations LLC under the on! PLUS brand through the premarket tobacco product application (PMTA) pathway.

    These authorizations mark the first decisions from a pilot program launched in September to streamline the review process for nicotine pouch applications while maintaining the agency’s rigorous scientific standards. Authorized products include mint, tobacco, and wintergreen flavors in 6 mg and 9 mg nicotine strengths. The FDA noted that these products contain lower levels of harmful constituents compared with other smokeless tobacco products and do not contain measurable levels of several carcinogens linked to oral cancer.

    “While today’s actions permit these specific nicotine pouch products to be legally marketed in the U.S. to adults 21 and older, it does not mean these tobacco products are safe, nor are they ‘FDA approved,’” FDA said in a statement.  

    All packaging will feature certified child-resistant cans.

  • USITC Launches Probe Following Juul Complaint

    USITC Launches Probe Following Juul Complaint

    The U.S. International Trade Commission instituted a Section 337 investigation after a complaint filed by Juul Labs, Inc. and VMR Products LLC alleging patent infringement involving certain vaporizer devices, cartridges, and related components. The complaint, filed on September 30 and supplemented in November and December, asserts infringement of two U.S. patents—Nos. 11,134,722 and 11,606,981—through the importation and sale of the accused products in the United States. The investigation covers ENDS devices, pods, and components such as atomizers and subassemblies.

    Juul and VMR, both based in Washington, D.C., are seeking a limited exclusion order and cease and desist orders. The named respondents are Glas, Inc. and Glas, LLC of Los Angeles. The USITC said its Office of Unfair Import Investigations will not participate in the case.

  • El Septimo 20th Anniversary Cigar Sells Out Worldwide

    El Septimo 20th Anniversary Cigar Sells Out Worldwide

    El Septimo Cigars announced the complete global sell-out of its 20th Anniversary Doble Gran Reserva, marking a historic milestone for the brand. Limited to just 1,000 boxes of 14 cigars—14,000 cigars total—the release sold out worldwide in under seven months, making it the fastest-selling new cigar in the company’s history.

    Created by CEO Zaya Younan to commemorate El Septimo’s 20th anniversary, the cigar was produced with extensively aged tobaccos and positioned as the company’s most personal and ambitious release to date. Younan said the rapid sell-out reflects the brand’s focus on extreme patience, uncompromising quality, and craftsmanship. The company said it will not be reproduced.

  • Cannabis Co. Says NY’s Seed-to-Sale Regs Create Undue Costs

    Cannabis Co. Says NY’s Seed-to-Sale Regs Create Undue Costs

    Cannabis company Veterans Holdings, Inc filed a lawsuit this week in New York Supreme Court against the state, challenging its seed-to-sale tracking system, arguing it significantly increases operating and compliance costs for licensed businesses. The program, overseen by the Office of Cannabis Management, requires cannabis products to be tracked from cultivation through retail sale using the “Metrc” platform.

    According to the company, and echoed by other growers and processors, the program’s tagging, reporting, and data-entry requirements sharply increase compliance expenses, particularly for smaller operators. Businesses say costs associated with mandatory tags, system integration, staff training, and ongoing reporting could erode already thin margins in the state’s developing legal cannabis market.

  • Morocco Plans Cigarette Hikes January 1

    Morocco Plans Cigarette Hikes January 1

    Morocco is set to increase cigarette prices at the beginning of 2026 following the completion of a report by the commission responsible for approving tobacco prices, according to Le360. The report has been submitted to the Minister of Economy and Finance, ahead of a ministerial decree expected to be published in the Official Bulletin. The measure is part of the government’s gradual reform of tobacco taxation aimed at narrowing price gaps between cigarette categories and boosting state revenues.

    The price increase could reach up to MAD 2 ($0.22) per pack for widely consumed “popular” cigarette brands, including Marquise, Casa, and Fortuna. Gauloises may see a smaller adjustment, while premium brands are not expected to be affected at this stage. The increase is scheduled to take effect on January 1, 2026, and is likely to have the greatest impact on lower-income consumers, who predominantly purchase popular brands.

    Under this plan, the specific Internal Consumption Tax component will rise from MAD 100 ($11) in 2022 to MAD 550 ($60.50) by 2026, while the minimum tax on 1,000 cigarettes will increase from MAD 710.2 ($78.12) to MAD 953 ($104.83), adding continued upward pressure on retail prices.

  • Trump Reclassifies/Downgrades Marijuana

    Trump Reclassifies/Downgrades Marijuana

    President Donald Trump signed an executive order today (December 18) directing the reclassification of marijuana as a less dangerous drug, marking a significant shift in U.S. federal drug policy. The move would downgrade cannabis from a Schedule I substance—alongside heroin and LSD—to Schedule III, a category that includes ketamine and some anabolic steroids. While the change would not legalize recreational marijuana nationwide, it could ease regulations, lower tax burdens on the cannabis industry, and expand opportunities for medical research.

    The order is expected to accelerate a review process already underway at the Drug Enforcement Administration, which typically involves extensive public consultation. A similar reclassification effort was proposed under former President Joe Biden, but Trump’s decision has drawn mixed reactions within his own party. Some Republicans strongly oppose any change, arguing marijuana remains harmful to public health and safety, while public opinion has shifted sharply in favor of legalization, with recent polling showing more than two-thirds of Americans support a less restrictive approach.

    Trump’s order also calls for expanded research into cannabis and increased access to CBD products. While the president has emphasized a tough stance on drugs such as fentanyl, he has framed marijuana policy as an area where federal rules should better reflect state-level changes. More than 20 states have legalized recreational marijuana or allow medical use, though federal law has continued to impose stricter limits and potential criminal penalties.

  • Türkiye Working to Cut Smoking Rate

    Türkiye Working to Cut Smoking Rate

    Türkiye’s Health Minister Kemal Memişoğlu said that smoking remains one of the country’s most serious public health challenges, with nearly one in three people using tobacco. Speaking in Ankara, he called for urgent action to reduce smoking rates and said Türkiye should no longer rank among Europe’s heaviest-smoking nations.

    Memişoğlu said Türkiye is among the world’s top three countries for lung cancer cases, and stressed that most smokers want to quit and outlined expanded government efforts, including free smoking cessation services, mobile clinics in public spaces, and counseling and medication offered through family health and healthy life centers.

    The minister also highlighted broader investments in preventive healthcare, including the expansion of family health centers and healthy life centers focused on early diagnosis, screenings, and lifestyle guidance.

  • Indonesia Sounds Alarm on Drug-Laced Vapes

    Indonesia Sounds Alarm on Drug-Laced Vapes

    On December 16, Indonesia’s National Narcotics Agency (BNN) warned of the growing circulation of drug-laced vape cartridges containing the anesthetic etomidate, following a major seizure at Soekarno-Hatta International Airport. Authorities intercepted 8,500 illicit vape refill cartridges smuggled through air cargo routes on November 12 and arrested a distributor in a joint operation by BNN and the National Police.

    BNN said etomidate, now classified as a Schedule II narcotic, poses serious health risks when inhaled through vaping due to the lack of dosage control. Officials warned that repeated use can lead to dependency. BNN cited national data showing 1.73% of Indonesia’s population (about 3.3 million people) have been exposed to drugs, and claimed that the country’s estimated 70 million smokers increase vulnerability to drug-laced vape products.

  • Dutch Study Finds Fewer People Seeing GPs to Stop Smoking

    Dutch Study Finds Fewer People Seeing GPs to Stop Smoking

    Fewer people in the Netherlands are visiting general practitioners for help quitting smoking since the start of the COVID-19 pandemic, according to new research by health services institute Nivel. Nivel said smoking rates dropped only slightly—from 21.7% in 2019 to 19% in 2023—while vaping increased during the same period, and that changes in reimbursement cannot explain the decline.

    While GP services largely recovered after an initial drop during the pandemic, requests for smoking cessation support did not rebound. Although the study did not provide the exact number, it stated that consultations for quitting smoking in 2023 reached their lowest level since records began in 2014, despite the expansion of insurance coverage for cessation support since 2020. The study also found that patients have been visiting GPs less frequently for education-, work-, and social-related issues since the pandemic.

  • Federal Judge Allows Deceptive Claim in Zyn Case

    Federal Judge Allows Deceptive Claim in Zyn Case

    A federal judge in Florida has allowed deceptive practices claims against Philip Morris International (PMI) and its subsidiaries to move forward, according to Law360. On December 12, U.S. District Judge William P. Dimitrouleas of the Southern District of Florida denied the companies’ motion to dismiss claims brought by plaintiff Kovadis Palmer under the Florida Deceptive and Unfair Trade Practices Act (FDUTPA).

    Palmer alleges that PMI and Swedish Match North America LLC misleadingly marketed Zyn nicotine pouches as “tobacco-free,” suggesting a lower addiction risk even though the nicotine is derived from tobacco. He claims he developed nicotine dependence as a result. While the court previously dismissed Palmer’s common-law fraud claims for failing to meet heightened pleading standards, it found that the amended FDUTPA claims advance a distinct legal theory.

    The judge ruled that FDUTPA claims do not require proof of intent to deceive and are not subject to the stricter fraud pleading rules. As a result, the court held that the claims are not merely a repackaging of dismissed fraud allegations and may proceed.